Plato, Munro invest in SpaceX as rival funds wait for the sellers

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

Alex Gluyas

Plato, Munro invest in SpaceX as rival funds wait for the sellers

June 11, 2026
“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.
Read Transcript

Munro Partners and Plato Investment Management are among the few Australian growth funds to invest in Elon Musk’s SpaceX IPO while most of their rivals are sitting back until the world’s hottest stock becomes cheaper.

Nick Griffin, chief investment officer of the $9.1 billion money manager Munro Partners, said he was making a small investment in the rocket company, which is set to hit the boards in New York on Friday (Saturday AEST).

While Griffin acknowledged that SpaceX’s $US1.8 trillion ($2.57 trillion) valuation was expensive, he wanted to ensure that Munro had some exposure should the stock continue to surge well beyond its market debut.

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

The investment chief thinks that opportunity could present itself in a matter of months when insider lock-ups expire and private investors start to cash in.

Musk himself has agreed not to sell any of his roughly 40 per cent stake for at least a year after the IPO.

“If you look at the big IPOs such as Google, Facebook, Uber and even Spotify, there’s so much money that had to come out, so many private investors in SpaceX will have to sell in the next 12 months or two years,” Griffin said. “That private-to-public hand-off usually provides opportunities.”

Plato Investment Management is adopting a similar strategy and is buying shares via the IPO to build a position that will be roughly in line with SpaceX’s weighting on the index.

“[It is] enough to avoid being badly wrong if these businesses do become the next Amazon or Nvidia, but not so much that we’re hostage to a valuation that leaves no room for error,” said David Allen, who runs Plato’s $4.2 billion Global Alpha Fund.

Allen warned that SpaceX was trading on a price to revenue of 100 times, which implied that everything needed to go right for the company, including the technology, competition, regulation and execution.

“When you pay 100 times revenue for a business, you’re not buying a company, you’re buying a specific version of the future,” said the hedge fund manager.

“In our experience, the future has a habit of surprising even the most careful forecasters.”

While Allen has said that SpaceX was likely to make an attractive short in the future – that is when an investor makes money from a stock’s decline – he warned that building a short position now was fraught with risk.

“With a wave of retail money chasing what will likely be a limited free float at IPO, there’s little upside in betting heavily against these on day one,” he said.

While Plato and Munro are dabbling in SpaceX, some fund managers are holding back for now, while others, including Antipodes, are avoiding the company altogether.

A ‘trust me’ story


Alex Pollak, who runs Loftus Peak’s $1.5 billion Global Disruption strategy, said while SpaceX would likely rally in the first few sessions of trading at least, he was still happy to watch from the sidelines.

Pollak pointed to S&P’s decision not to change the rules for a company to join its major indices. That policy contrasted with rivals Nasdaq and FTSE Russell, which recently tweaked their ​requirements.

To join the S&P 500 Index, a company must trade publicly for at least a year, be ‌profitable under US accounting standards and hold a free float of at least 10 per cent. SpaceX meets none of those requirements.

The rocket company posted a net loss of $US4.9 billion last year, while revenue rose 33 per cent ​to $18.6 billion. It has never been profitable.

“The float is clearly oversubscribed and the stock will probably go up, but we’re not investors,” said Pollak.

“To win a place in our portfolio, you need to have the possibility of stock price performance, and risks have to be controlled, but that is not the case with SpaceX because it’s just a ‘trust me’ story.”

Ziller Funds Management has also opted out despite SpaceX ticking many of the boxes required to be eligible for a position in its Ziller Global Fund, including the company being led by its billionaire founder.

Investment chief Joseph Ziller said he was bullish on the space theme, but not on the hefty valuation.

“Reliable launch is in extremely short supply because it’s incredibly difficult to do,” said Ziller.

“The only two players doing it are SpaceX and Rocket Lab, so the supply-constrained nature of the industry means the unit economics are very attractive.”

Ziller held a stake in Rocket Lab but has recently trimmed its position, given the stock has almost quadrupled in value over the past year.

“SpaceX is a similar situation – we’re not so interested at these valuations,” Ziller said. “There will be an opportunity over the next six months to 12 months to get in at a more attractive price.”

Hedge fund manager Jack Hu, who runs the Phoenix Growth Fund, built up a position in SpaceX earlier in the year after taking part in a funding round.

While that stake will be subject to a mandatory lock-up period, Hu has applied for another allocation through the IPO.

If successful, Hu said he planned to sell those shares in the first few days of trading as passive and benchmark-aware investors send the stock soaring.

Munro Partners and Plato Investment Management are among the few Australian growth funds to invest in Elon Musk’s SpaceX IPO while most of their rivals are sitting back until the world’s hottest stock becomes cheaper.

Nick Griffin, chief investment officer of the $9.1 billion money manager Munro Partners, said he was making a small investment in the rocket company, which is set to hit the boards in New York on Friday (Saturday AEST).

While Griffin acknowledged that SpaceX’s $US1.8 trillion ($2.57 trillion) valuation was expensive, he wanted to ensure that Munro had some exposure should the stock continue to surge well beyond its market debut.

“We love the company and, like any Elon company, it is unique and has amazing long-term opportunities, but the price is a little hard to stomach, so hopefully we get a better opportunity,” said Griffin.

The investment chief thinks that opportunity could present itself in a matter of months when insider lock-ups expire and private investors start to cash in.

Musk himself has agreed not to sell any of his roughly 40 per cent stake for at least a year after the IPO.

“If you look at the big IPOs such as Google, Facebook, Uber and even Spotify, there’s so much money that had to come out, so many private investors in SpaceX will have to sell in the next 12 months or two years,” Griffin said. “That private-to-public hand-off usually provides opportunities.”

Plato Investment Management is adopting a similar strategy and is buying shares via the IPO to build a position that will be roughly in line with SpaceX’s weighting on the index.

“[It is] enough to avoid being badly wrong if these businesses do become the next Amazon or Nvidia, but not so much that we’re hostage to a valuation that leaves no room for error,” said David Allen, who runs Plato’s $4.2 billion Global Alpha Fund.

Allen warned that SpaceX was trading on a price to revenue of 100 times, which implied that everything needed to go right for the company, including the technology, competition, regulation and execution.

“When you pay 100 times revenue for a business, you’re not buying a company, you’re buying a specific version of the future,” said the hedge fund manager.

“In our experience, the future has a habit of surprising even the most careful forecasters.”

While Allen has said that SpaceX was likely to make an attractive short in the future – that is when an investor makes money from a stock’s decline – he warned that building a short position now was fraught with risk.

“With a wave of retail money chasing what will likely be a limited free float at IPO, there’s little upside in betting heavily against these on day one,” he said.

While Plato and Munro are dabbling in SpaceX, some fund managers are holding back for now, while others, including Antipodes, are avoiding the company altogether.

A ‘trust me’ story


Alex Pollak, who runs Loftus Peak’s $1.5 billion Global Disruption strategy, said while SpaceX would likely rally in the first few sessions of trading at least, he was still happy to watch from the sidelines.

Pollak pointed to S&P’s decision not to change the rules for a company to join its major indices. That policy contrasted with rivals Nasdaq and FTSE Russell, which recently tweaked their ​requirements.

To join the S&P 500 Index, a company must trade publicly for at least a year, be ‌profitable under US accounting standards and hold a free float of at least 10 per cent. SpaceX meets none of those requirements.

The rocket company posted a net loss of $US4.9 billion last year, while revenue rose 33 per cent ​to $18.6 billion. It has never been profitable.

“The float is clearly oversubscribed and the stock will probably go up, but we’re not investors,” said Pollak.

“To win a place in our portfolio, you need to have the possibility of stock price performance, and risks have to be controlled, but that is not the case with SpaceX because it’s just a ‘trust me’ story.”

Ziller Funds Management has also opted out despite SpaceX ticking many of the boxes required to be eligible for a position in its Ziller Global Fund, including the company being led by its billionaire founder.

Investment chief Joseph Ziller said he was bullish on the space theme, but not on the hefty valuation.

“Reliable launch is in extremely short supply because it’s incredibly difficult to do,” said Ziller.

“The only two players doing it are SpaceX and Rocket Lab, so the supply-constrained nature of the industry means the unit economics are very attractive.”

Ziller held a stake in Rocket Lab but has recently trimmed its position, given the stock has almost quadrupled in value over the past year.

“SpaceX is a similar situation – we’re not so interested at these valuations,” Ziller said. “There will be an opportunity over the next six months to 12 months to get in at a more attractive price.”

Hedge fund manager Jack Hu, who runs the Phoenix Growth Fund, built up a position in SpaceX earlier in the year after taking part in a funding round.

While that stake will be subject to a mandatory lock-up period, Hu has applied for another allocation through the IPO.

If successful, Hu said he planned to sell those shares in the first few days of trading as passive and benchmark-aware investors send the stock soaring.

Disclaimer: This material has been prepared by Australian Financial Review, published on June 11, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
May 25, 2026

Finding the edge: data, AI and active investing

Markets are moving faster than ever. AI is changing how investment managers research, think and ultimately make decisions. Hear from Magellan on finding the edge and knowing how to use it.

Read More
May 31, 2026

Munro Partners’ Nick Griffin on picking the few winners and avoiding the losers in global equities

Nick explains why his team focuses on investing in structurally growing companies and the main characteristics to look for in identifying those that will be the long-term winners. Nick also shares his views on structural themes that are providing the tailwinds from which winners will emerge.

Read More
March 3, 2025

The investing megatrends you can’t ignore (and some you should rethink)

James Marlay of Livewire sat down with Vihari Ross of Antipodes (HM1 Conference Fund Manager) and James Tsinidis of Munro Partners (HM1 Core Fund Manager) to discuss the biggest megatrends shaping the future.

Read More
January 6, 2025

Resources fundies reveal top picks ahead of ‘stellar’ 2025

Some of Australia’s biggest resources funds are gearing up for a bumper start to the new year.

Read More
December 28, 2024

10 top fund managers reveal their long-term stock picks

With valuations stretched and geopolitical tensions high, the new year offers plenty of potholes for investors.

Read More
November 26, 2024

How Trump will impact equity markets

The United States has spoken. President Trump has returned to the White House. But how can we cut through the noise to reveal the investment, economic and geopolitical ramifications?

Read More
Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.Ellerston Capital’s Chris Kourtis appeared at the Sohn Hearts and Minds conference on Friday. Picture: Ben Searcy.
November 18, 2024

These rock-star stock picks could get markets talking next year

Eleven rock stars of international and local funds management took to stage – each tasked with picking and pitching one company whose shares will take off over the next year.

Read More
Tech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben SearcyTech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben SearcyTech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben SearcyTech pioneer Paul Bassat said incumbent companies will be hit hard by AI start-ups. Picture: Ben Searcy
November 15, 2024

AI start-ups a threat to incumbent big companies

Paul Bassat predicts emerging artificial intelligence companies will disrupt sectors and overtake established incumbent companies just as rapidly as the seismic shifts that took place when the internet emerged in the mid-1990s.

Read More
September 16, 2024

With Purpose podcast with Michael Traill

Tune in to hear from Michael Traill AM, Executive Director of For Purpose Investment Partners, Chair of the Paul Ramsay Foundation, and HM1 Board Director.

Read More
June 19, 2024

Nvidia became the biggest company in the world. Now what?

Now that Nvidia has reached the milestone of becoming the biggest company in the world, what does its future hold?

Read More
June 11, 2024

Nine stocks to buy and hold forever

The younger the investor, the more time they have to earn life-changing capital gains by staying invested in the market over the long term.

Read More
June 2, 2024

What's next for Guzman y Gomez?

Equity Mates recently spoke with Guzman y Gomez co-CEOs Steven Marks and Hilton Brett to talk about what next for the Mexican quick service restaurant giant now that they have joined the ASX.

Read More
April 30, 2024

Magellan decode the Magnificent Seven

Get the latest insights from Magellan on the Magnificent 7 (NVIDIA, Meta, Tesla, Amazon, Microsoft, Alphabet Inc. Apple) including profitability, fundamentals and the future.

Read More
February 26, 2024

Chipping away at the semiconductor market

In a recent episode of In The Know, the team at Magellan discuss the outlook for the Semiconductor chip industry covering many stocks in HM1's portfolio including their recommended stock for our core portfolio.

Read More
July 4, 2023

The Artificial Intelligence Era

The semiconductor industry is entering its fourth phase - the Artificial Intelligence  era. Over roughly 50 years, the semiconductor market has gone from a nascent industry to about the size of 500bn USD today.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.